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ABSTRACT
Telomeres, the ends of linear chromosomes, safe-
guard against genome instability. The enzyme re-
sponsible for extension of the telomere 30 terminus
is the ribonucleoprotein telomerase. Whereas tel-
omerase activity can be reconstituted in vitro with
only the telomerase RNA (hTR) and telomerase
reverse transcriptase (TERT), additional compo-
nents are required in vivo for enzyme assembly, sta-
bility and telomere extension activity. One such
associated protein, dyskerin, promotes hTR stability
in vivo and is the only component to co-purify with
active, endogenous human telomerase. We used
oligonucleotide-based affinity purification of hTR
followed by native gel electrophoresis and in-gel tel-
omerase activity detection to query the composition
of telomerase at different purification stringencies.
At low salt concentrations (0.1M NaCl), affinity-
purified telomerase was ‘supershifted’ with an
anti-dyskerin antibody, however the association
with dyskerin was lost after purification at 0.6M
NaCl, despite the retention of telomerase activity
and a comparable yield of hTR. The interaction of
purified hTR and dyskerin in vitro displayed a
similar salt-sensitive interaction. These results dem-
onstrate that endogenous human telomerase, once
assembled and active, does not require dyskerin for
catalytic activity. Native gel electrophoresis may
prove useful in the characterization of telomerase
complexes under various physiological conditions.
INTRODUCTION
In eukaryotic cells linear chromosome ends are protected
by telomeres, a repetitive tract of G-rich DNA recognized
and stabilized by protein complexes such as shelterin,
which execute telomere-speciﬁc and more generalized
functions in suppressing a DNA damage response (1). In
all but a few eukaryotic species the enzyme responsible for
the maintenance of telomere length is telomerase, a
ribonucleoprotein that extends the 30 G-rich terminal
overhang co-ordinately with C-strand replication by con-
ventional DNA polymerases (2). In vitro, it is possible to
reconstitute human, yeast and ciliate telomerase activities
in crude rabbit reticulocyte extracts by expressing only
the telomerase RNA (TER, or hTR in humans) and the
telomerase reverse transcriptase (TERT) (3–7). This crude
extract supplies the chaperones essential for the assembly
of these two components into an active complex (7–9).
Thus, the telomerase core enzyme consists minimally of
TERT and TER.
The characterization of endogenous telomerase has
been hampered by its extremely low abundance, even in
organisms replete with telomeres such as ciliates (10). One
solution to this challenge has been the expression and
puriﬁcation of tagged telomerase components, which
further identiﬁed several proteins important in telomerase
assembly and regulation (11–16). Native human telomer-
ase puriﬁed from cell extracts varies in mass from 550kDa
to 1MDa, supporting the notion of telomerase subunit
multimerization or the presence of additional components
(17–19). One successful approach for the puriﬁcation of
endogenous telomerase employs oligonucleotides that
bind the telomerase RNA with high afﬁnity, ﬁrst described
in the characterization of the telomerase RNA itself (20)
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humans (18,19,21–23). For example, in Euplotes crassus
the La ortholog p43 is tightly associated with
afﬁnity-puriﬁed telomerase and facilitates processive
telomere extension in vitro and in vivo (24–26). In
another large-scale puriﬁcation, endogenous human tel-
omerase was isolated from 10
9 immortalized human cells
and contained just three subunits: hTERT, hTR and
dyskerin (18). Thus, akin to other large DNA replication
machineries there is a core enzyme consisting of rela-
tively few components augmented by various additional
components that regulate assembly, localization and
activity (11–16).
Processing of the telomerase RNA is highly regulated
and differs between species. In mammals, the
pseudouridylase dyskerin is required for maturation of
snoRNAs and for the stability of the telomerase RNA
in vivo (27,28). hTR, like other members of the snoRNA
family, possesses an H/ACA box, and although it has not
yet been reported as a target for pseudouridylation in vivo,
it binds the other pseudouridylase accessory factors
NOP10, NHP2 and GAR1 (28,29). Unlike other
snoRNAs that are generated from introns (30), hTR is
an intron-less RNA that is transcribed by RNA pol II
(31,32). hTR also contains a CAB box that is required
for localization to Cajal bodies (33,34). hTR distribution
is regulated among nucleoplasmic, nucleolar and Cajal
body compartments, and several RNA processing
pathways appear involved in its maturation into an
active telomerase RNP (33–36). In Saccharomyces
cerevisiae, processing of the telomerase RNA TLC1
occurs between the cytoplasm and nucleus, and is
regulated by Crm1p and Mtr10p (37,38). Sm proteins,
which play a critical role in the biogenesis, transport and
function of snRNP particles, associate with human tel-
omerase (39) and serve to stabilize TLC1 in S. cerevisiae
(40). Despite the absence of introns in the telomerase
RNA gene of S. pombe (ter1+), the spliceosome is none-
theless critical for TER1 30 processing (41). The telomerase
RNA thus employs various RNA processing pathways
that facilitate its localization, stability and assembly into
active telomerase.
Mutations that affect the stability, activity or telomere
recruitment of telomerase have a profound impact on stem
cell function and lifespan in mammals. Mutations in
dyskerin (DKC1) are associated with X-linked
dyskeratosis congenita (DKC); in addition to dyskerin,
some patients affected with autosomal DKC carry
mutations in NOP10, NHP2, Terc (hTR), TERT, the
telomerase-associated protein TCAB1 (WRAP53) and
shelterin components such as TIN2 (TINF2) (42–44).
Telomere attrition as a result of reduced telomerase
activity appears to account for many of the manifestations
of this disease, and mutations in Terc and Tert, are also
linked to aplastic anaemia, pulmonary lung ﬁbrosis and
cancer (45–47). In fact, the co-incidence of aplastic
anaemia and pulmonary ﬁbrosis in patient families is
highly predictive of a telomerase mutation (48). The
critical role of hTR in human disease is also underscored
by the ability of hTR upregulation or enforced expression
to rescue the proliferative and telomere maintenance
defects in patient-derived cells carrying mutations in
hTR or dyskerin (49–51). DKC-like phenotypes are
recapitulated in mice with limiting levels of TR (52,53),
especially when combined with a Pot1 deﬁciency (54,55).
Even in a wild-type murine background, short telomeres
confer a DKC-like phenotype (53,56). Likely due to
profound effects on all H/ACA-containing RNAs, mice
deﬁcient in dyskerin (Dkc1) exhibit early embryonic lethal-
ity (57). Thus, genetic evidence in mice and humans dem-
onstrates unequivocally that critically short telomeres are
pathological.
Improvements in the detection of endogenous human
telomerase would further illuminate the regulation of
telomerase assembly and composition in normal and
diseased states. Native gel electrophoresis and the
electromobility shift assay (EMSA) have been used
previously to detect the incorporation of exogenously
synthesized hTR into partially puriﬁed human telomerase
(58) and to probe the association of telomerase with the
telomerase RNA-binding proteins p80 and TEP1 (59–61).
EMSA has also been employed to assess the association of
endogenous, puriﬁed ciliate telomerase (21) and of recom-
binant hTERT fragments (62) with telomeric DNA. Here,
we used native gel electrophoresis to assess the mobility of
endogenous human telomerase after afﬁnity puriﬁcation
at different salt concentrations, and demonstrated the
ability to purify endogenous telomerase that retained
activity yet lacked dyskerin.
MATERIALS AND METHODS
Cell culture and lysate preparation
Raji cells, a human lymphoblastic cell line, were grown in
RPMI 1640 media supplemented with 10% v/v FBS and
2mM L-glutamine in a 100-l reactor at Amgen, Inc.
(Thousand Oaks, CA, USA), harvested in mid-log
phase, washed in PBS and frozen in liquid nitrogen. For
each frozen pellet of  2 10
10 cells, the cells were thawed
and resuspended in an equal volume (100ml) of 2.3  hypo
buffer (23mM HEPES, 7mM KCl, 2.3mM MgCl2) sup-
plemented with protease inhibitor cocktail tablets
(Roche), RNase inhibitor (20U/ml; Roche) and 1mM
DTT (63). The mixture was subjected to 90 strokes in a
Dounce homogenizer with a loose pestle, on ice. The
lysate was adjusted to 0.1M NaCl or 0.6M NaCl and
incubated at 4 C for 45min. Each lysate was then
centrifuged at 140000g in a SW28 Ti rotor (Beckman) at
4 C for 1h. The supernatant was removed, adjusted to
15% v/v glycerol and snap frozen.
Anti-sense afﬁnity puriﬁcation of telomerase
Three hundred microlitres of Ultralink Immobilized
Neutravidin Protein Plus (Pierce) was washed with 2.3 
hypo buffer containing 0.1M or 0.6M NaCl and 0.5% v/v
Triton X-100. Thirty nanomoles of afﬁnity oligonucleo-
tide 50-biotin-CTAGACCTGTCACCUUCUCAGUUA
GG-30 (19,23,63) was coupled to the resin and washed in
2.3  hypo buffer containing 0.1M or 0.6M NaCl. A
15-ml aliquot of cell extract (corresponding to 1.5 10
9
cells) was thawed and pre-cleared by centrifugation at
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resin and incubated for 10min, with rocking, at 30 C
followed by 2h at 4 C. The resin was then collected by
brief centrifugation (700 g for 2min) and transferred to a
5-ml disposable Bio-spin Column (Bio-Rad, Hercules,
CA, USA) and washed at 4 C with 2.3  hypo buffer con-
taining 0.5% v/v Triton X-100 in 0.6M NaCl or 0.1M
NaCl. The last wash, irrespective of initial salt concentra-
tion, was performed with 1ml of 2.3  hypo buffer con-
taining 0.1M NaCl and 10% v/v glycerol. Elution was
performed by addition of the displacement oligonucleotide
50-CCTAACTGAGAAGGTGACAGGTCTAG-30 at a
ratio of 3nmol oligonucleotide/nmol of biotinylated
afﬁnity oligonucleotide (19,23,63) in 1ml of 2.3  hypo
buffer containing 0.1M NaCl and 10% v/v glycerol. The
elution step was repeated again for a total of 2 1ml
eluate fractions that were subsequently pooled, adjusted
to 20% v/v glycerol and stored at  70 C.
In vitro transcription of hTR and hvg1
Human telomerase RNA (hTR) and the human vault
RNA (hvg1) RNAs were synthesized with the Ribomax
Large-Scale RNA Production System-T7 (Promega, UK)
as per the manufacturer’s instructions. Telomerase RNA
(hTR) was transcribed from pUC-hTR (1–451) digested
with EcoRI or the same plasmid digested with StuI to
generate a truncated hTR lacking the H/ACA box (nt
1–352) (3), and hvg1 RNA was transcribed from the
HindIII-linearized pUC118-hvg1 (1–98) plasmid (64).
Transcription products were puriﬁed using MEGAclear
(Ambion, Austin, TX, USA), according to manufacturer’s
instructions.
Semi-quantitative RT-PCR of hTR or hvg1
RNA abundance was assessed by semi-quantitative
RT-PCR using the Qiagen OneStep RT-PCR kit
according to manufacturer’s instructions in a 20-ml
reaction volume (Qiagen, UK). Ampliﬁcation of
hTR employed primers 50-GGTGGTGGCCATTTTTTG
TC-30 (forward) and 50-CTAGAATGAACGGTGGAA
GGC-30 (reverse; at 0.6mM each). In experiments where
puriﬁed hvg1 was added as an ampliﬁcation control
(Figures 3 and 4), 0.1mM of hvg1 forward primer 50-GG
CTTTAGCTCAGCGGTTACTTCG-30, and 0.1mM hvg1
reverse primer 50-GCGCCCGCGGGTCTCGAAC-30
were included in the reaction. Approximately one-third
volume of each reaction was resolved by electrophoresis
on a 2% w/v agarose/TAE (Tris–Acetate–EDTA) gel and
stained with ethidium bromide. Gel images were acquired
on a Bio-Rad Geldoc XR using Quantity One 4.6.1 1D
Analysis software.
Native gel electrophoresis
Non-denaturing gels contained 3.5% w/v polyacrylamide
(acrylamide:bisacrylamide, 60:1) and 0.4% w/v agarose,
and samples were subjected to electrophoresis in 75mM
Tris–glycine buffer (pre-chilled). Approximately 75ml
afﬁnity puriﬁed sample (corresponding to  10–45mgo f
total protein, or the amount of material puriﬁed from
the equivalent of 10
7 cells) was loaded per well.
Immediately following electrophoresis, the gel was sliced
into 13 equal sections. Each lane was placed in a 1.5-ml
microcentrifuge tube with 200ml of elution buffer (10mM
Tris–HCl pH 8.3, 1.5mM MgCl2, 10mM KCl) and eluted
overnight at 4 C. Eluates were stored at  70 C, and were
used subsequently for TRAP and RT–PCR analysis
(below). For each native gel, one outside lane was
loaded with 20mg of thyroglobulin gel ﬁltration marker
(AP Biosciences, UK).
Mobility shift experiments
Seventy-ﬁve microlitres of puriﬁed sample after afﬁnity
puriﬁcation (corresponding to  10–45mg of total
protein) was incubated with 1ml (1U) RNase-free
DNaseI (Roche, Mannehim, Germany) and 10mg of the
indicated antibody for 75min at 4 C with gentle agitation.
As a negative control, antibody was boiled at 95 C for
5min prior to mixing. Samples were then loaded onto
native gels and processed as described earlier. Antibodies
employed were anti-hTERT (276–294), generated and
puriﬁed according to Cohen et al., 2007 (18), and
anti-dyskerin, H300 or H300X (10-fold further
concentrated) (Santa Cruz).
TRAP assay and RT–PCR
For each of the 13 native gel slice eluates, 15ml was
assayed for telomerase activity by the Trapeze
Telomerase Detection kit (Millipore, Temecula, CA,
USA) according to the manufacturer’s instructions, and
10ml was assayed for hTR in RT–PCR reactions as
described earlier. In Figures 3 and 4, all RT–PCR reac-
tions were ‘spiked’ with puriﬁed hvg1 RNA as an internal
PCR control. hTR and hvg1 signals were quantiﬁed from
gel images using ImageQuant 5.2 software (Molecular
Dynamics) and ImageJ (NIH). Each hTR signal was
normalized to its respective hvg1 signal. TRAP versus
hTR signals were plotted across all 13 fractions using
Image J, by subtracting a background lane (i.e. containing
no sample) from the same-sized object encompassing
TRAP or hTR signal, and dividing each by the 36-bp
internal control (for TRAP) or hvg1 (for hTR), respect-
ively. Fractions containing the peak hTR (and TRAP)
signal were assigned in at least ﬁve independent experi-
mental replicates, and the difference between the mean
peak fractions assessed using a Student’s t-test.
Assessment of hTR yield was carried out using Image J
quantiﬁcation of puriﬁed hTR titrations and ﬁtting indi-
vidual samples to the linear response curve.
Recombinant dyskerin puriﬁcation from Escherichia coli
The human dyskerin gene (Full-length Mammalian
gene collection ID 4303933-Invitrogen, Oslo, Norway)
was cloned into a vector containing HIS-tag, pET30
(Novagen), to enable puriﬁcation from E. coli. BL21
Codon Plus RIL cells (Stratagene, La Jolla, CA, USA)
were transformed and grown at 37 C. The liquid culture
was induced with 1mM IPTG for 4h at 30 C, and lysed
with Tris 50mM, 10mM imidazole and 300mM NaCl
containing protease inhibitors (Roche, Mannheim
Germany) and lysozyme (Sigma, UK) (0.25mg/ml).
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30% amplitude on a sonicator Vibra Cell (Jencons). The
bacterial lysate was clariﬁed by centrifugation at 15000g
and loaded on a 1-ml Hitrap IMAC charged with Ni
2+
(GE healthcare, UK) using an AKTA Explorer (GE
Healthcare, UK). The column was washed with 20
volumes at 50mM imidazole, and the protein was eluted
with linear gradient (50–500mM imidazole, 20 column
volumes). The purity and concentration of dyskerin was
evaluated by the Bradford assay (Bio-Rad, Munchen,
Germany) and via Coomassie staining of the sample
after resolution by SDS–PAGE. The purity of dyskerin
ranged between 80% and 85%. The eluate was adjusted
to 50% glycerol and stored at  80 C. Western blot
analysis of recombinant or endogenous dyskerin
employed H300X, C15 (Santa Cruz) or anti-Dys1
provided by P. Mason (65,66).
hTR labelling and immunoprecipitation
Full-length hTR (1–451) or hTR (1–352) was produced
by in vitro transcription in the presence of Cy5-UTP
(Perkin Elmer, Waltham, USA) using Ribomax
Large-Scale RNA Production System-T7 (Promega,
Madison, USA) according to the manufacturer’s instruc-
tions (the rNTP mixture contained 1mM each of CTP,
GTP, ATP and 0.64mM UTP with 0.56mM Cy5-UTP).
The reaction was terminated by treatment with DNAse for
15min and RNA was extracted using RNeasy minelute
(Qiagen, UK). The RNA was denatured and refolded
using a thermocycler (Bio-Rad, UK) by decreasing the
temperature from 95 Ct o2 3  C via 0.1 C increments per
second. For immunoprecipitation, 2mg of recombinant
dyskerin was incubated on ice with 20ng of Cy5-hTR in
300mlo f1   hypo buffer, adjusted to 0.1 or 0.6M NaCl,
for 1h. Four micrograms of anti-dyskerin antibody
(H300X, Santa Cruz) was added and incubated for a
further hour. Five microlitres of protein A-conjugated
Dynabead solution (Invitrogen), previously equilibrated
in 1  hypobuffer at 0.1M NaCl or 0.6M NaCl, was
incubated with the mixture for 30min. After four washes
in 1  hypobuffer adjusted to 0.1M NaCl, or three washes
at 0.6M NaCl followed by one wash at 0.1M NaCl, the
beads were resuspended in 10ml1   hypobuffer, and
resolved via 6% w/v SDS–PAGE. The gel was subse-
quently scanned with a Li-Cor scanner (Li-Cor
Biosciences, UK) to detect Cy5-hTR and transferred
onto PVDF membrane and probed with goat dyskerin
antibody (C-15, Santa Cruz). The secondary antibody,
IRDye 800 donkey anti-goat (Li-Cor Biosciences),
permitted quantiﬁcation using an Odyssey scanner
(Odyssey Imaging system, Li-Cor Biosciences). Brieﬂy,
rectangular boxes of equal size were marked around
hTR and dyskerin on the respective images. Background
was subtracted based on average pixel intensity surround-
ing the rectangle, and a ratio of hTR/dyskerin calculated
for each sample. The experiment in Figure 5C is represen-
tative of four independent experiments; the graph in
Figure 5D represents triplicate samples for the same ex-
periment in Figure 5C. P-values for differences in
association at 0.1M versus 0.6M NaCl were calculated
using a two-tailed t-test, assuming unequal variance.
RESULTS
Puriﬁcation of telomerase by anti-sense afﬁnity selection
and native gel electrophoresis
In order to investigate the composition of endogenous tel-
omerase, we employed a previously developed puriﬁcation
strategy using anti-sense afﬁnity selection of hTR
(19,22,23), with minor modiﬁcations (63). A biotinylated
oligonucleotide containing a random sequence and a
region of complementarity to the human telomerase
RNA (hTR) (nt 50–64) was incubated with cell extracts
from a human lymphoblastoma cell line (Raji). The oligo-
nucleotide sequence differed slightly from that used in a
previous study (nt 46–59) (19), and was based on opti-
mization of the recovery of telomerase activity (63). Raji
cells were chosen because of the relatively low level of hTR
expression (35 copies/cell) (63) relative to other cell types
(19,67,68), in order to maximize the ratio of
afﬁnity-puriﬁed hTR associated with telomerase
activity. After incubation with Raji lysate, the afﬁnity
oligonucleotide was captured onto neutravidin beads,
washed and eluted by virtue of a displacement oligo-
nucleotide complementary to the afﬁnity oligonucleotide
(19,22,23,63). To further purify telomerase, this frac-
tion was resolved on a clear, 3.5% w/v non-denaturing
native acrylamide gel (Figure 1A). To locate active
telomerase after electrophoresis, the native gel was
separated into 1cm slices numbered from top to bottom
(e.g. Figure 1B, right), eluted into a buffered solution
and subjected to the telomere repeat ampliﬁcation
protocol (TRAP) (Figure 1A, bottom panel). One
adjacent lane of the native gel was stained with
Coomassie blue dye, while another adjacent lane was
probed for the presence of the telomerase RNA after
transfer to nylon membrane (Figure 1A, top panels).
These results demonstrated that the peak of endogenous
telomerase activity and hTR co-migrated on the native gel
at a position distinct from the bulk of proteins detected by
Coomassie staining.
We next assessed whether various treatments altered the
mobility of the endogenous human telomerase complex.
Similar to previously published results whereby telomerase
mass was estimated by velocity sedimentation or size
exclusion chromatography, we found that at low concen-
trations of NaCl (0.1M=LS), telomerase activity
migrated at an apparent molecular mass >670kDa
(thyroglobulin=T) (Figure 1C). Puriﬁcation at 37 C
(compared with 4 C) did not signiﬁcantly affect the
mobility of telomerase (Figure 1B and C) (63). The
faster mobility of hTR after proteinase K treatment
(Figure 1B and C), although variable between experiments
and not coincident with in vitro puriﬁed hTR (compare
lower two hTR panels in Figure 1C), nevertheless con-
ﬁrmed that the puriﬁed hTR complex contained protein.
Upon increasing the stringency of the puriﬁcation to 0.6M
NaCl the native mobility of human telomerase was
increased (Figures 1B and 2A) (17–19,22). Thus, hTR
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tion, which could reﬂect distinct properties including
protein composition.
To further characterize the composition of telomerase
puriﬁed at 0.1M versus 0.6M NaCl, we assessed hTR
recovery and its association with telomerase activity.
The peak of telomerase activity after native gel electro-
phoresis mirrored that of hTR regardless of salt concen-
tration; however, when averaged across seven
experiments, the hTR RT–PCR signal co-peaked with tel-
omerase activity at fraction 5.5±0.9 when puriﬁed at
0.1M NaCl, and at fraction 7.0±0.9 when puriﬁed at
0.6M NaCl (P<0.01) (Figure 2A; one representative ex-
periment shown). Despite the shift in mobility, the total
yield of telomerase RNA did not differ signiﬁcantly
between puriﬁcation at 0.1M versus 0.6M NaCl,
although, as expected, the total protein yield was lower
after puriﬁcation at 0.6M NaCl (Figure 2B and C). For
example, the hTR signal in the E1 eluate fraction after
puriﬁcation at 0.1 or 0.6M NaCl was 33 or 37fg, respect-
ively (Figure 2B, quantiﬁcation as described in ‘Materials
and Methods’ section). Northern analysis conﬁrmed that
hTR yields in 0.1 and 0.6M eluates were comparable and
varied between 3 and 4fmol from 5 10
9 Raji cells (data
not shown) (63). To demonstrate the selectivity of the
puriﬁcation for hTR, the more abundant hvg1 RNA
(64) did not co-precipitate with afﬁnity-puriﬁed telomer-
ase at 0.1 or 0.6M NaCl (Figure 2D, bottom panel),
despite the fact that hvg1 RNA was readily detected
when it was ‘spiked’ into the sample prior to RT–PCR
(Figure 2D, top panel). Thus, telomerase puriﬁed at
0.6M NaCl exhibited a faster mobility upon native gel
electrophoresis, yet the amount and yield of hTR was
comparable to puriﬁcation at 0.1M NaCl.
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Figure 1. Telomerase puriﬁcation via afﬁnity selection and native gel electrophoresis. (A) Co-migration of hTR and telomerase activity after native
gel electrophoresis of afﬁnity-puriﬁed Raji cell extract (at 0.1M NaCl). After clear native gel electrophoresis, one lane was stained with Coomassie
blue (top panel; gel slice oriented from top to bottom as indicated), and one lane probed with a radiolabelled probe corresponding to hTR after
transfer to nylon (middle panel). A third lane was sliced into 13 fractions, eluted into buffer and subjected to the telomere repeat ampliﬁcation
protocol, TRAP (bottom panel). (B) Relative mobility of telomerase after native gel electrophoresis and detection with a radiolabelled probe
corresponding to hTR. Lane 1, in vitro transcribed hTR alone; Raji cell extracts puriﬁed at 0.1 MNaCl (low stringency; LS) and 0.6M NaCl
(high stringency; HS) at 4 C (lanes 2 and 3, respectively), 37 C (lanes 4 and 6) and after incubation with proteinase K (lanes 5 and 7). Brackets at
right indicate position of gel slices. (C) The indicated treatments as in (B) were resolved by native gel electrophoresis, sliced into 13 fractions and
subjected to TRAP (upper panels) and RT–PCR analysis to detect the native mobility of hTR (lower panels). Thyroglobulin (T) was loaded onto an
adjacent lane of the native gel; its position is indicated with an arrow, top. Asterisk indicates TRAP internal PCR standard; arrows at right, hTR.
The bottom panel represents PCR detection of hTR after native gel electrophoresis of puriﬁed, in vitro transcribed hTR alone (no added extract). At
right, 1.0 and 0.2ml of rabbit reticulocyte lysate (RRL) containing reconstituted telomerase activity, or water alone ( ) as positive and negative
controls for TRAP, respectively.
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telomerase mobility
The migration of a protein complex on a native gel
depends not only on the molecular mass but also upon
its charge and hydrodynamic status (69). To test
whether the difference in the migration of telomerase re-
ﬂected different protein compositions, we employed
a well-characterized property of antibodies to ‘supershift’
their cognate protein upon binding to the complex during
electrophoresis (70). Since dyskerin is a tightly associated
telomerase subunit (18), we tested the ability of an
anti-dyskerin antibody (H-300X, Santa Cruz) to
supershift telomerase at 0.1M NaCl. H300X recognized
endogenous murine wild-type (57kDa) and a truncated
Dkc1 variant lacking exon 15 and the C-terminal 21
amino acids, Dkc
15 (55kDa) (66) with a similar speciﬁ-
city as an independently generated dyskerin antibody
(Dys
M) (65) (Figure 3A). In addition, H300X recognized
recombinant human dyskerin and a single polypeptide of
the expected molecular mass (57kDa) in human cell
lysates (Figures 4 and 5). H300X elicited a signiﬁcant
mobility retardation of telomerase relative to sample
without added antibody (Figure 3B and C, one represen-
tative experiment shown), with the peak of RT–PCR hTR
signal and telomerase activity shifting from fraction
5.5±0.9 to 4.4±0.2 upon incubation with H300X
(n=5,P<0.01). This mobility shift was abolished when
the H300X antibody was boiled prior to incubation with
telomerase (Figure 3B and C). Thus, a signiﬁcant fraction
of telomerase puriﬁed at 0.1M NaCl contained dyskerin,
in accord with Cohen et al. (18) who found a stoichiomet-
ric association of dyskerin with telomerase upon puriﬁca-
tion at 0.3M KCl.
Other antibodies directed against TERT or telomerase-
associated subunits failed to supershift the telomerase
complex in native gels. Two antibodies directed against
the telomerase-associated subunit SMG-6/EST1A (71)
and another commercial anti-dyskerin antibody (C-15,
Santa Cruz) were unable to supershift telomerase (data
not shown). In addition, we failed to observe a statistically
signiﬁcant supershift using polyclonal rabbit antibodies
generated against the reverse transcriptase domain of
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276–294) (18), despite their demonstrated speciﬁcity for
TERT as published previously (Figure 3B–D and data
not shown) (18,72). These observations may reﬂect the
fact that it is relatively uncommon for an antibody to
supershift its target in native gels (70).
The TERT and dyskerin antibodies were tested for their
ability to supershift the telomerase complex after afﬁnity
puriﬁcation at 0.6M NaCl (Figure 4). The anti-hTERT
peptide (amino acids 276–294) antibody elicited a slight
(but not statistically signiﬁcant) retardation in the
mobility of active telomerase (Figure 4A and B). In
contrast to the effect upon telomerase puriﬁed at 0.1M
NaCl, H300X did not retard the mobility of telomerase
activity or hTR relative to no added antibody (Figure 4A
and B). Western blot analysis of the 0.1- and 0.6-M eluates
after afﬁnity puriﬁcation conﬁrmed that dyskerin was lost
from the complex after puriﬁcation at 0.6M NaCl
(Figure 4C, lanes 3 and 4), despite a comparable level of
dyskerin in lysates prior to afﬁnity puriﬁcation
(Figure 4C, lanes 5 and 6). Thus, despite a comparable
recovery of hTR, telomerase complexes puriﬁed
at 0.6M NaCl had lost an association with dyskerin.
Immunoprecipitation using unpuriﬁed Raji cell lysates
conﬁrmed a similar ability of H300X to recover dyskerin
at 0.1 and 0.6M NaCl (data not shown). The salt sensi-
tivity of the dyskerin–telomerase interaction was also
reproduced in unpuriﬁed Raji cell lysates using the
anti-TERT 276P antibody, which immunopuriﬁed
dyskerin at 0.1M NaCl but not at 0.6M NaCl (data not
shown).
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dyskerin in vitro
Since dyskerin interacts directly with hTR, we tested the
possibility that higher salt concentrations would dissociate
the hTR–dyskerin complex. Human dyskerin was puriﬁed
from E. coli (Figure 5A) and incubated with Cy5-labelled
hTR. Cy5-hTR was conﬁrmed for its competence to re-
constitute active telomerase in vitro (Figure 5B). Despite
the fact that hTR was produced in vitro (and thus only
a subset of molecules may be in a conformation competent
to interact with dyskerin), the H300X antibody
immunopuriﬁed Cy5-hTR, or a Cy5-labelled hTR trunca-
tion lacking the H/ACA box (hTR; nt 1–352), and this
ability depended on the presence of dyskerin (Figure 5C,
lanes 4–6 and 8). However, the interaction of dyskerin
with hTR or hTR was abolished if the immu-
noprepitation procedure was carried out at 0.6M NaCl
(Figure 5C, lanes 7 and 9; Figure 5D). Thus, the
T
E
R
T
2
7
6
P
(
H
S
)
D
Y
S
1
H
3
0
0
X
(
H
S
)
n
o
 
A
b
 
(
H
S
)
T
*
*
*
hTR
hvg1
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
i
n
t
e
n
s
i
t
y
 
(
a
.
u
.
) T
TRAP
hTR
AB
C
LS HS LS HS
DYS1
eluate input 293T
ß-tubulin
*
D
Y
S
1
H
3
0
0
X
(
L
S
)
3 1 1 2 3 4 5 6 7 8 9 101112
0.0
0.2
0.4
0.6
0.8
1.0
1.2
3 1 1 2 3 4 5 6 7 8 9 101112
DYS1
56
1234
Figure 4. Supershift analysis of native telomerase after puriﬁcation at high stringency. (A) Telomerase activity and hTR distribution proﬁles of
telomerase puriﬁed at high stringency (HS; 0.6M NaCl) after incubation with no antibody (top panel), TERT anti-peptide antibody (276P) (second
panel) or dyskerin antibody (DysH300X) (last panel), each incubated with extracts prior to native gel electrophoresis (see ‘Materials and Methods’
section). For comparison, the incubation of Dys
H300X with telomerase puriﬁed at 0.1M NaCl (LS; third panel, as in Figure 3) is shown. Asterisk
indicates internal control for TRAP PCR reactions; black arrow indicates hTR; grey arrow indicates exogenous hvg1 RNA added to the RT–PCR
reaction mixture as an internal control. T indicates mobility of thyroglobulin (top arrow). (B) The same proﬁles as in (A) represented graphically,
after normalization to the respective internal PCR controls. Dark grey; TRAP, light grey; hTR. Lane numbers correspond to eluate fractions.
(C) 293T cell extract, 24 and 240mg, respectively, LS and HS eluates and input material (5%) were resolved by SDS–PAGE (on the same gel, but
lanes are separated to omit irrelevant material) and analysed by western blotting with the anti-dyskerin antibody. Bottom panel, 40mg of the same
input extracts (LS, HS) were probed simultaneously with anti-dyskerin and anti-b-tubulin as a loading control.
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in vitro may account for the loss of dyskerin associated
with active telomerase after puriﬁcation at 0.6M NaCl.
The ability of dyskerin to bind hTR, which lacks the
H/ACA box, is in general agreement with previous
studies that established that snoRNAs lacking an
H/ACA box still bound Cbf5 (the dyskerin homologue
in S. cerevisiae), albeit at a lower afﬁnity than RNAs con-
taining the H/ACA motif (73).
DISCUSSION
We utilized native gel electrophoresis to evaluate the
mobility of telomerase after partial puriﬁcation. This tech-
nique, combined with the ability of an anti-dyskerin
antibody to supershift the telomerase complex, enabled
the identiﬁcation of distinct telomerase complexes after
puriﬁcation under low and high salt concentrations. In
accord with Cohen et al. (18), dyskerin was an integral
component of the telomerase complex when puriﬁed at
0.1M NaCl, based on a signiﬁcant supershift of
telomerase in native gels with an anti-dyskerin antibody.
However, puriﬁcation at 0.6M NaCl resulted in an active
telomerase complex that lacked dyskerin. Depending on
the relative stoichoimetry of TERT, hTR and dyskerin
within telomerase, other proteins dispensable for catalytic
activity may also have been dissociated during puriﬁcation
at 0.6M NaCl. For example, although three other integral
components of the H/ACA binding complex, NHP2,
NOP10 and GAR1, were not identiﬁed in the large-scale
afﬁnity puriﬁcation of endogenous telomerase (18), they
are associated with puriﬁed, tagged TR or TERT (29,74).
Previous studies established a role for dyskerin in the
stability of hTR in vivo and its ability to assemble into an
active telomerase complex (49,75,76). However the neces-
sity of its continued association with the enzyme had not
been assessed. In vitro, addition of exogenous dyskerin is
not required for telomerase reconstitution in crude cell
extracts (3,4,8). Our results demonstrate that, once
assembled, the association of dyskerin with native tel-
omerase from cell extracts is also dispensable for catalytic
activity. These results support the notion that the critical
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assembly and stability (14).
This study extends the utility of native gel electrophor-
esis to the analysis of endogenous human telomerase
complexes. Previously, native gel analysis of puriﬁed tel-
omerase from Tetrahymena thermophila led to the identi-
ﬁcation of a  125kDa protein with a telomere speciﬁc
and RNase-sensitive DNA binding activity (21), and
native gels also established a critical role of the telomerase
RNA pseudoknot in telomerase assembly (60). In humans,
native gels were employed to examine the association of
recombinant telomerase RNA with partially puriﬁed tel-
omerase (58), and the association of endogenous telomer-
ase RNA and activity with an anti-Ro60 antibody
cross-reacting species hypothesized to be the telomerase
RNA-associated protein TEP1 (59,61,77,78). Whereas
large amounts of starting material are required to
analyse endogenous complexes by mass spectrometry
(18), smaller amounts can be probed by native gel electro-
phoresis if an antibody of sufﬁcient speciﬁcity and avidity
is available. This methodology permits analysis under
various conditions where immuno-tagging would be
otherwise impractical, for example, in different tissues
under various physiological or diseased states. This
method could also be used to assess binding of candidate
small molecules or peptides, in which case the molecule
could be ﬂuorescently labelled and assessed for
co-migration with the complex. This approach may there-
fore be of general interest to probe the composition and
binding properties of telomerase and other complexes
isolated from physiological sources.
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